Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04527003 · ClinicalTrials.gov registry record · Phase 3
Cannabidiol and Management of Endometriosis Pain
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 12
- Enrollment target
NCT04527003 is a Phase 3 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 12 participants.
The verdict
NCT04527003, a Phase 3 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 12 participants
- Enrollment target
Study Summary
The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) in patients with endometriosis. It is believed that CBD will improve both pain and quality of life. The study will last a total of 12 weeks and involve several onsite visits in addition to daily pain assessments.
Interventions
- OTHER Placebo
- DRUG Norethindrone Acetate
- DRUG Cannabidiol (CBD) Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-12-04 |
| Est. Completion | 2024-06-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04527003
The ClinicalTrials.gov registry entry for NCT04527003 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04527003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04527003 about?
NCT04527003 is a clinical study titled "Cannabidiol and Management of Endometriosis Pain". The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) in patients with endometriosis. It is believed that CBD will improve both pain and quality of life. The study will last a total of 12 weeks and involve several onsite visits in addition to daily pain assessm...
What is the current status of trial NCT04527003?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2020-12-04. Estimated completion is 2024-06-26.
What interventions are being tested in trial NCT04527003?
The interventions under investigation include: Placebo (OTHER), Norethindrone Acetate (DRUG), Cannabidiol (CBD) Extract (DRUG).
Who is sponsoring clinical trial NCT04527003?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.